A rare case of Epstein-Barr virus-induced Bell’s palsy in an 18-year-old highlights the need for EBV testing in sudden facial ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...